Acrivon Therapeutics shares owned by Vanguard Group
Quarter-by-quarter ownership of Acrivon Therapeutics (ACRV) shares owned by Vanguard Group
from 13F filings
Historical chart of Vanguard Group investment in Acrivon Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Acrivon Therapeutics held by Vanguard Group consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Acrivon Therapeutics by Vanguard Group
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-09-30 | $1.1M | 626k | 1.81 |
| 2025-06-30 | $706k | 593k | 1.19 |
| 2025-03-31 | $1.4M | 675k | 2.03 |
| 2024-12-31 | $4.0M | 672k | 6.02 |
| 2024-09-30 | $4.5M | 638k | 7.00 |
| 2024-06-30 | $4.3M | 746k | 5.80 |
| 2024-03-31 | $3.6M | 507k | 7.15 |
| 2023-12-31 | $2.3M | 476k | 4.92 |
| 2023-09-30 | $4.5M | 468k | 9.56 |
| 2023-06-30 | $5.2M | 403k | 12.96 |
| 2023-03-31 | $5.2M | 409k | 12.69 |